School of Pharmacy, University of Otago, Dunedin, New Zealand.
School of Pharmacy, International Medical University (IMU), Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
AAPS PharmSciTech. 2018 Feb;19(2):769-782. doi: 10.1208/s12249-017-0883-1. Epub 2017 Oct 6.
Protein biologics are prone to conformational changes during formulation development. Limited methods are available for conformational analysis of proteins in solid state and in the presences of formulation excipients. The aim of this study was to investigate the secondary structures of proteins encased in solid lipid matrices as a novel indicator of their stability upon in vitro release. Model proteins namely catalase and lysozyme were incorporated into lipid namely Precirol® AT05 (glycerol palmitostearate, melting point 58°C) at 30% w/w loading using melting and mixing and wet granulation methods. Attenuated total reflectance (ATR-FTIR) spectroscopy, size-exclusion chromatography (SEC) and biological activity analyses were performed. The information about secondary structure was acquired using second derivative analysis of amide-I band (1600-1700 cm). ATR analysis demonstrated interference of lipid spectrum with protein amide-I band which was subsequently subtracted to allow the analysis of the secondary structure. ATR spectra amide-I bands showed shifts peak band positions compared to native protein for matrices prepared using wet granulation. SEC analysis gave evidence of protein aggregation for catalase which was increased using wet granulation. The biological activity of catalase was statistically different from that of control and was affected by the incorporation method and was found to be in alignment with ATR spectral changes and extent of aggregation. In conclusion, ATR spectroscopy could analyze protein secondary structure in lipid matrices provided lipid interference was minimized. The ATR spectral changes and formation of aggregates can indicate the loss in biological activity of protein released from solid lipid matrices.
蛋白质生物制剂在制剂开发过程中容易发生构象变化。目前可用于分析固态和制剂辅料存在下蛋白质构象的方法有限。本研究旨在探讨包裹在固体脂质基质中的蛋白质的二级结构,作为其在体外释放时稳定性的新指标。模型蛋白即过氧化氢酶和溶菌酶以 30%w/w 的载药量掺入脂质即 Precirol® AT05(甘油棕榈硬脂酸酯,熔点 58°C)中,采用熔融混合和湿法制粒法。进行衰减全反射(ATR-FTIR)光谱、尺寸排阻色谱(SEC)和生物活性分析。使用酰胺 I 带(1600-1700cm)的二阶导数分析获取二级结构信息。ATR 分析表明脂质光谱与蛋白质酰胺 I 带存在干扰,随后对其进行扣除,以允许分析二级结构。与使用湿法制粒法制备的基质相比,ATR 光谱酰胺 I 带的峰带位置发生了偏移。SEC 分析表明过氧化氢酶发生了聚集,使用湿法制粒法后,聚集程度增加。过氧化氢酶的生物活性与对照相比具有统计学差异,并且受到掺入方法的影响,与 ATR 光谱变化和聚集程度一致。总之,ATR 光谱法可以分析脂质基质中蛋白质的二级结构,前提是最小化脂质干扰。ATR 光谱的变化和聚集的形成可以表明从固体脂质基质中释放的蛋白质的生物活性丧失。